-
1
-
-
70350513270
-
Regulation of tissue homeostasis by NF-κB signalling: Implications for inflammatory diseases
-
Pasparakis M. Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9(11):778-788.
-
(2009)
Nat Rev Immunol.
, vol.9
, Issue.11
, pp. 778-788
-
-
Pasparakis, M.1
-
2
-
-
84855172814
-
The pathogenesis of rheumatoid arthritis
-
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-2219.
-
(2011)
N Engl J Med.
, vol.365
, Issue.23
, pp. 2205-2219
-
-
McInnes, I.B.1
Schett, G.2
-
3
-
-
73449125837
-
New insights in synovial angiogenesis
-
Szekanecz Z, Besenyei T, Paragh G, Koch AE. New insights in synovial angiogenesis. Joint Bone Spine. 2009;77(1):13-19.
-
(2009)
Joint Bone Spine.
, vol.77
, Issue.1
, pp. 13-19
-
-
Szekanecz, Z.1
Besenyei, T.2
Paragh, G.3
Koch, A.E.4
-
4
-
-
77950285549
-
Angiogenesis and vasculogenesis in rheumatoid arthritis
-
Szekanecz Z, Besenyei T, Szentpetery A, Koch AE. Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol. 2010;22(3):299-306.
-
(2010)
Curr Opin Rheumatol.
, vol.22
, Issue.3
, pp. 299-306
-
-
Szekanecz, Z.1
Besenyei, T.2
Szentpetery, A.3
Koch, A.E.4
-
5
-
-
84858213225
-
Biologic agents in rheumatoid arthritis: An update for managed care professionals
-
Agarwal SK. Biologic agents in rheumatoid arthritis: an update for managed care professionals. J Manag Care Pharm. 2011;17(9):S14-S18.
-
(2011)
J Manag Care Pharm.
, vol.17
, Issue.9
, pp. S14-S18
-
-
Agarwal, S.K.1
-
6
-
-
34447336406
-
Longterm infliximab treatment in rheumatoid arthritis: Subsequent outcome of initial responders
-
Buch MH, Bingham SJ, Bryer D, Emery P. Longterm infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford). 2007;46(7):1153-1156.
-
(2007)
Rheumatology (Oxford).
, vol.46
, Issue.7
, pp. 1153-1156
-
-
Buch, M.H.1
Bingham, S.J.2
Bryer, D.3
Emery, P.4
-
7
-
-
84879806081
-
Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis
-
Feist E, Burmester GR. Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2013;52(8):1352-1357.
-
(2013)
Rheumatology (Oxford).
, vol.52
, Issue.8
, pp. 1352-1357
-
-
Feist, E.1
Burmester, G.R.2
-
8
-
-
42949171833
-
Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation
-
Simmonds RE, Foxwell BM. Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation. Rheumatology (Oxford). 2008;47(5):584-590.
-
(2008)
Rheumatology (Oxford).
, vol.47
, Issue.5
, pp. 584-590
-
-
Simmonds, R.E.1
Foxwell, B.M.2
-
9
-
-
59449108567
-
The roles of the classical and alternative nuclear factorkappaB pathways: Potential implications for autoimmunity and rheumatoid arthritis
-
Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factorkappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):212.
-
(2008)
Arthritis Res Ther.
, vol.10
, Issue.4
, pp. 212
-
-
Brown, K.D.1
Claudio, E.2
Siebenlist, U.3
-
10
-
-
73249147432
-
Gene discovery in rheumatoid arthritis highlights the CD40/NF-κB signaling pathway in disease pathogenesis
-
Criswell LA. Gene discovery in rheumatoid arthritis highlights the CD40/NF-κB signaling pathway in disease pathogenesis. Immunol Rev. 2010;233(1):55-61.
-
(2010)
Immunol Rev.
, vol.233
, Issue.1
, pp. 55-61
-
-
Criswell, L.A.1
-
11
-
-
82455162312
-
Negative regulation of NF-kappaB and its involvement in rheumatoid arthritis
-
Van Loo G, Beyaert R. Negative regulation of NF-kappaB and its involvement in rheumatoid arthritis. Arthritis Res Ther. 2011;13(3):221.
-
(2011)
Arthritis Res Ther.
, vol.13
, Issue.3
, pp. 221
-
-
Van Loo, G.1
Beyaert, R.2
-
12
-
-
38849199203
-
Shared principles in NF-κB signaling
-
Hayden MS, Ghosh S. Shared principles in NF-κB signaling. Cell. 2008;132(3):344-362.
-
(2008)
Cell
, vol.132
, Issue.3
, pp. 344-362
-
-
Hayden, M.S.1
Ghosh, S.2
-
13
-
-
84873433098
-
Melittin derived peptides for nanoparticle based siRNA transfection
-
Hou KK, Pan H, Lanza GM, Wickline SA. Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials. 2013;34(12):3110-3119.
-
(2013)
Biomaterials.
, vol.34
, Issue.12
, pp. 3110-3119
-
-
Hou, K.K.1
Pan, H.2
Lanza, G.M.3
Wickline, S.A.4
-
14
-
-
84887009773
-
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides
-
Hou KK, Pan H, Ratner L, Schlesinger PH, Wickline SA. Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. AC S Nano. 2013;7(10):8605-8615.
-
(2013)
AC S Nano.
, vol.7
, Issue.10
, pp. 8605-8615
-
-
Hou, K.K.1
Pan, H.2
Ratner, L.3
Schlesinger, P.H.4
Wickline, S.A.5
-
15
-
-
0014670341
-
Interaction of alytic polypeptide, melittin, with lipid membrane systems
-
Sessa G, Freer JH, Colacicco G, Weissmann G. Interaction of alytic polypeptide, melittin, with lipid membrane systems. J Biol Chem. 1969;244(13):3575-3582.
-
(1969)
J Biol Chem.
, vol.244
, Issue.13
, pp. 3575-3582
-
-
Sessa, G.1
Freer, J.H.2
Colacicco, G.3
Weissmann, G.4
-
16
-
-
77955802263
-
Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures
-
Pan H, et al. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J. 2010;24(8):2928-2937.
-
(2010)
FASEB J.
, vol.24
, Issue.8
, pp. 2928-2937
-
-
Pan, H.1
-
17
-
-
0018830639
-
Immunisation against heterologous type II collagen induces arthritis in mice
-
Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980;283(5748):666-668.
-
(1980)
Nature
, vol.283
, Issue.5748
, pp. 666-668
-
-
Courtenay, J.S.1
Dallman, M.J.2
Dayan, A.D.3
Martin, A.4
Mosedale, B.5
-
18
-
-
0022295359
-
Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci
-
Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med. 1985;162(6):1878-1891.
-
(1985)
J Exp Med.
, vol.162
, Issue.6
, pp. 1878-1891
-
-
Watson, W.C.1
Townes, A.S.2
-
19
-
-
0026600294
-
Induction of arthritis with monoclonal antibodies to collagen
-
Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Immunol. 1992;148(7):2103-2108.
-
(1992)
J Immunol.
, vol.148
, Issue.7
, pp. 2103-2108
-
-
Terato, K.1
Hasty, K.A.2
Reife, R.A.3
Cremer, M.A.4
Kang, A.H.5
Stuart, J.M.6
-
20
-
-
84872405597
-
In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier
-
Naeye B, et al. In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. Biomaterials. 2013;34(9):2350-2358.
-
(2013)
Biomaterials.
, vol.34
, Issue.9
, pp. 2350-2358
-
-
Naeye, B.1
-
21
-
-
78650943096
-
Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces
-
Pham CT, et al. Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces. J Biol Chem. 2011;286(1):123-130.
-
(2011)
J Biol Chem.
, vol.286
, Issue.1
, pp. 123-130
-
-
Pham, C.T.1
-
22
-
-
84896542810
-
Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles
-
Pham CT, et al. Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles. Nanomedicine. 2014;10(3):651-660.
-
(2014)
Nanomedicine.
, vol.10
, Issue.3
, pp. 651-660
-
-
Pham, C.T.1
-
23
-
-
9144219693
-
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
-
Godl K, et al. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci U S A. 2003;100(26):15434-15439.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, Issue.26
, pp. 15434-15439
-
-
Godl, K.1
-
24
-
-
79954580272
-
Current prospects for RNA interference-based therapies
-
Davidson BL, McCray PB, McCray PB Jr. Current prospects for RNA interference-based therapies. Nat Rev Genet. 2011;12(5):329-340.
-
(2011)
Nat Rev Genet.
, vol.12
, Issue.5
, pp. 329-340
-
-
Davidson, B.L.1
McCray, P.B.2
Mccray, P.B.3
-
25
-
-
17244378648
-
Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis
-
Schiffelers RM, Xu J, Storm G, Woodle MC, Scaria PV. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Ar thritis Rheum. 2005;52(4):1314-1318.
-
(2005)
Ar Thritis Rheum.
, vol.52
, Issue.4
, pp. 1314-1318
-
-
Schiffelers, R.M.1
Xu, J.2
Storm, G.3
Woodle, M.C.4
Scaria, P.V.5
-
26
-
-
33745014998
-
Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis
-
Khoury M, et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum. 2006;54(6):1867-1877.
-
(2006)
Arthritis Rheum.
, vol.54
, Issue.6
, pp. 1867-1877
-
-
Khoury, M.1
-
27
-
-
49549101615
-
Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes
-
Khoury M, et al. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis Rheum. 2008;58(8):2356-2367.
-
(2008)
Arthritis Rheum.
, vol.58
, Issue.8
, pp. 2356-2367
-
-
Khoury, M.1
-
28
-
-
84892424496
-
Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis
-
Zhang T, Bai X, Mao X. Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis. PLoS One. 2013;8(11):e78619.
-
(2013)
PLoS One.
, vol.8
, Issue.11
, pp. e78619
-
-
Zhang, T.1
Bai, X.2
Mao, X.3
-
29
-
-
84895903061
-
TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis
-
Lee SJ, et al. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther. 2014;22(2):397-408.
-
(2014)
Mol Ther.
, vol.22
, Issue.2
, pp. 397-408
-
-
Lee, S.J.1
-
30
-
-
84903782299
-
Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis
-
Duan J, et al. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis. Nanomedicine (Lond). 2014;9(6):789-801.
-
(2014)
Nanomedicine (Lond).
, vol.9
, Issue.6
, pp. 789-801
-
-
Duan, J.1
-
31
-
-
33746438424
-
Toxicity of cationic lipids and cationic polymers in gene delivery
-
Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006;114(1):100-109.
-
(2006)
J Control Release.
, vol.114
, Issue.1
, pp. 100-109
-
-
Lv, H.1
Zhang, S.2
Wang, B.3
Cui, S.4
Yan, J.5
-
32
-
-
67349267016
-
Addressing the problem of cationic lipid-mediated toxicity: The magnetoliposome model
-
Soenen SJ, Brisson AR, De Cuyper M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials. 2009;30(22):3691-3701.
-
(2009)
Biomaterials.
, vol.30
, Issue.22
, pp. 3691-3701
-
-
Soenen, S.J.1
Brisson, A.R.2
De Cuyper, M.3
-
34
-
-
0029789793
-
Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
-
Plank C, Mechtler K, Szoka FC, Szoka FC Jr, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther. 1996;7(12):1437-1446.
-
(1996)
Hum Gene Ther.
, vol.7
, Issue.12
, pp. 1437-1446
-
-
Plank, C.1
Mechtler, K.2
Szoka, F.C.3
Szoka, F.C.4
Wagner, E.5
-
35
-
-
0021701974
-
The activation of the complement system by polymer materials and their blood compatibility
-
Sevast'ianov VI, Tseytlina EA. The activation of the complement system by polymer materials and their blood compatibility. J Biomed Mater Res. 1984;18(9):969-978.
-
(1984)
J Biomed Mater Res.
, vol.18
, Issue.9
, pp. 969-978
-
-
Sevast'ianov, V.I.1
Tseytlina, E.A.2
-
36
-
-
80052154470
-
Material properties in complement activation
-
Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen TL, Hunter AC. Material properties in complement activation. Adv Drug Deliv Rev. 2011;63(12):1000-1007.
-
(2011)
Adv Drug Deliv Rev.
, vol.63
, Issue.12
, pp. 1000-1007
-
-
Moghimi, S.M.1
Andersen, A.J.2
Ahmadvand, D.3
Wibroe, P.P.4
Andresen, T.L.5
Hunter, A.C.6
-
37
-
-
84859031194
-
Postformulation peptide drug loading of nanostructures
-
Pan H, et al. Postformulation peptide drug loading of nanostructures. Methods Enzymol. 2012;508:17-39.
-
(2012)
Methods Enzymol.
, vol.508
, pp. 17-39
-
-
Pan, H.1
-
38
-
-
84871868348
-
Programmable nanoparticle functionalization for in vivo targeting
-
Pan H, et al. Programmable nanoparticle functionalization for in vivo targeting. FASEB J. 2013;27(1):255-264.
-
(2013)
FASEB J.
, vol.27
, Issue.1
, pp. 255-264
-
-
Pan, H.1
-
39
-
-
44449136550
-
Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides
-
Soman NR, Lanza GM, Heuser JM, Schlesinger PH, Wickline SA. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. Nano Le tt. 2008;8(4):1131-1136.
-
(2008)
Nano le tt.
, vol.8
, Issue.4
, pp. 1131-1136
-
-
Soman, N.R.1
Lanza, G.M.2
Heuser, J.M.3
Schlesinger, P.H.4
Wickline, S.A.5
-
40
-
-
70349220917
-
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
-
Soman NR, et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest. 2009;119(9):2830-2842.
-
(2009)
J Clin Invest.
, vol.119
, Issue.9
, pp. 2830-2842
-
-
Soman, N.R.1
-
41
-
-
80155200721
-
Therapeutic siRNA silencing in inflammatory monocytes in mice
-
Leuschner F, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011;29(11):1005-1010.
-
(2011)
Nat Biotechnol.
, vol.29
, Issue.11
, pp. 1005-1010
-
-
Leuschner, F.1
-
42
-
-
70349334687
-
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice
-
Zhou HF, Chan HW, Wickline SA, Lanza GM, Pham CT. Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J. 2009;23(9):2978-2985.
-
(2009)
FASEB J.
, vol.23
, Issue.9
, pp. 2978-2985
-
-
Zhou, H.F.1
Chan, H.W.2
Wickline, S.A.3
Lanza, G.M.4
Pham, C.T.5
-
43
-
-
77957562101
-
Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis
-
Zhou HF, Hu G, Wickline SA, Lanza GM, Pham CT. Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomedicine (Lond). 2010;5(7):1065-1074.
-
(2010)
Nanomedicine (Lond).
, vol.5
, Issue.7
, pp. 1065-1074
-
-
Zhou, H.F.1
Hu, G.2
Wickline, S.A.3
Lanza, G.M.4
Pham, C.T.5
-
44
-
-
0036168150
-
Dipeptidyl peptidase I activates neutrophilderived serine proteases and regulates the development of acute experimental arthritis
-
Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophilderived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest. 2002;109(3):363-371.
-
(2002)
J Clin Invest.
, vol.109
, Issue.3
, pp. 363-371
-
-
Adkison, A.M.1
Raptis, S.Z.2
Kelley, D.G.3
Pham, C.T.4
|